FC
Finepoint Capital Portfolio holdings
AUM
$504M
This Quarter Return
-4.6%
1 Year Return
-3.16%
3 Year Return
+45.14%
5 Year Return
–
10 Year Return
–
AUM
$593M
AUM Growth
+$593M
(-32%)
Cap. Flow
-$196M
Cap. Flow
% of AUM
-33.1%
Top 10 Holdings %
Top 10 Hldgs %
92.38%
Holding
26
New
–
Increased
–
Reduced
17
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Liberty Broadband Class C
LBRDK
|
$126M |
| 2 |
argenx
ARGX
|
$32.6M |
| 3 |
Liberty Live Group Series C
LLYVK
|
$25.9M |
| 4 |
QXO
QXO Inc
QXO
|
$6.31M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
$889K |
Sector Composition
| 1 | Industrials | 55.89% |
| 2 | Healthcare | 31.46% |
| 3 | Communication Services | 12.57% |
| 4 | Energy | 0.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
QXO
1
QXO Inc
QXO
$13.6B
| $331M | 25.27% | 24,468,160 -465,665 | -2% | -$6.31M |
|
|
2
Liberty Broadband Class C
LBRDK
$8.73B
| $45M | 3.43% | 529,240 -1,486,470 | -74% | -$126M |
|
|
SWTX
3
DELISTED
SpringWorks Therapeutics
SWTX
| $32.2M | 2.45% | 728,602 -20,150 | -3% | -$889K |
|
|
4
Liberty Live Group Series C
LLYVK
$8.95B
| $29.5M | 2.25% | 432,895 -379,897 | -47% | -$25.9M |
|
5
Ascendis Pharma
ASND
$11.8B
| $28M | 2.14% | 179,872 -5,000 | -3% | -$779K |
|
6
Revolution Medicines
RVMD
$7.1B
| $24.4M | 1.86% | 691,260 -19,000 | -3% | -$672K |
|
7
MoonLake Immunotherapeutics
MLTX
$3.54B
| $17M | 1.3% | 435,785 -12,150 | -3% | -$475K |
|
8
Galapagos
GLPG
$2.07B
| $16.5M | 1.26% | 656,587 -18,175 | -3% | -$457K |
|
9
Cytokinetics
CYTK
$4.23B
| $12.5M | 0.95% | 309,948 -8,500 | -3% | -$342K |
|
10
Avidity Biosciences
RNA
$5.99B
| $11.2M | 0.86% | 380,700 -10,600 | -3% | -$313K |
|
11
Sarepta Therapeutics
SRPT
$1.78B
| $10.1M | 0.77% | 157,555 -4,380 | -3% | -$280K |
|
12
Prothena Corp
PRTA
$441M
| $7.92M | 0.6% | 640,071 -17,000 | -3% | -$210K |
|
13
Xencor
XNCR
$580M
| $6.83M | 0.52% | 642,200 -17,800 | -3% | -$189K |
|
14
EyePoint Pharmaceuticals
EYPT
$797M
| $5.86M | 0.45% | 1,081,954 -29,150 | -3% | -$158K |
|
15
Relay Therapeutics
RLAY
$619M
| $5.55M | 0.42% | 2,117,646 -58,000 | -3% | -$152K |
|
16
Arvinas
ARVN
$568M
| $4.87M | 0.37% | 694,028 -19,750 | -3% | -$139K |
|
17
Solid Biosciences
SLDB
$427M
| $3.56M | 0.27% | 961,251 | – | – |
|
|
ANNA
18
AleAnna, Inc. Class A Common Stock
ANNA
$165M
| $209K | 0.02% | 27,717 | – | – |
|
|
ANNAW
19
AleAnna, Inc. Warrant
ANNAW
$8.72M
| $122K | 0.01% | 490,000 | – | – |
|
|
GATEW
20
DELISTED
Marblegate Acquisition Corp. Warrant
GATEW
| $118K | 0.01% | 735,000 | – | – |
|
|
MNYWW
21
MoneyHero Limited Warrants
MNYWW
$1.89M
| $32.8K | ﹤0.01% | 895,000 | – | – |
|
|
LSBPW
22
LakeShore Biopharma Co., Ltd Warrants
LSBPW
$3.51M
| $20.2K | ﹤0.01% | 489,999 | – | – |
|
23
Calidi Biotherapeutics
CLDI
$8.83M
| $7.08K | ﹤0.01% | 12,499 -1 | -0% | -$1 |
|
|
24
argenx
ARGX
$43.6B
| – | – | -52,928 | Closed | -$32.6M |
|
25
iShares Russell 2000 ETF
IWM
$67B
| – | – | 0 | – | – |
|